Last reviewed · How we verify

Standard COVID-19 care

Liaquat University of Medical & Health Sciences · Phase 3 active Small molecule

Standard COVID-19 care encompasses supportive and therapeutic interventions including oxygen therapy, antivirals, corticosteroids, and anticoagulation to manage viral infection and prevent severe complications.

Standard COVID-19 care encompasses supportive and therapeutic interventions including oxygen therapy, antivirals, corticosteroids, and anticoagulation to manage viral infection and prevent severe complications. Used for COVID-19 (mild to severe).

At a glance

Generic nameStandard COVID-19 care
SponsorLiaquat University of Medical & Health Sciences
ModalitySmall molecule
Therapeutic areaInfectious Disease / Virology
PhasePhase 3

Mechanism of action

Standard COVID-19 care is a multimodal treatment approach rather than a single drug, typically including oxygen supplementation for hypoxemia, antiviral agents (such as remdesivir) to inhibit viral replication, corticosteroids (such as dexamethasone) to reduce excessive inflammation, and anticoagulation to prevent thrombotic complications. The approach is tailored to disease severity and patient factors.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: